These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38477025)

  • 61. Exploring the diagnostic potential of adding T2 dependence in diffusion-weighted MR imaging of the prostate.
    Syversen IF; Elschot M; Sandsmark E; Bertilsson H; Bathen TF; Goa PE
    PLoS One; 2021; 16(5):e0252387. PubMed ID: 34043735
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prostate Cancer Diffusion-Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion-Weighting Level Matter?
    Maier SE; Wallström J; Langkilde F; Johansson J; Kuczera S; Hugosson J; Hellström M
    J Magn Reson Imaging; 2022 Mar; 55(3):842-853. PubMed ID: 34535940
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Susceptibility artifacts and PIRADS 3 lesions in prostatic MRI: how often is the dynamic contrast-enhance sequence necessary?
    Antunes N; Vas D; Sebastia C; Salvador R; Ribal MJ; Nicolau C
    Abdom Radiol (NY); 2021 Jul; 46(7):3401-3409. PubMed ID: 33683430
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of apparent diffusion coefficient values in prostate diseases characterization on diffusion-weighted magnetic resonance imaging.
    Salvaggio G; Calamia M; Purpura P; Bartolotta TV; Picone D; Dispensa N; Lunetta C; Bruno A; Raso L; Salvaggio L; Lo Re G; Galia M; Simonato A; Midiri M; Lagalla R
    Minerva Urol Nefrol; 2019 Apr; 71(2):154-160. PubMed ID: 30421590
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differentiating prostate cancer from benign prostatic hyperplasia using whole-lesion histogram and texture analysis of diffusion- and T2-weighted imaging.
    Xing P; Chen L; Yang Q; Song T; Ma C; Grimm R; Fu C; Wang T; Peng W; Lu J
    Cancer Imaging; 2021 Sep; 21(1):54. PubMed ID: 34579789
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images.
    Tanaka O; Komeda H; Iida T; Tamaki M; Seike K; Kato D; Hirose S; Kawaguchi D; Yokoyama T
    Radiol Med; 2017 Mar; 122(3):204-207. PubMed ID: 27981486
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Objective value on Apparent diffusion coefficient (ADC) map to categorize the intensity of diffusion-weighted imaging (DWI) restriction for prostate cancer detection on multiparametric prostate MRI.
    Mussi TC; Martins T; Tachibana A; Mousessian PN; Baroni RH
    Int Braz J Urol; 2018; 44(5):882-891. PubMed ID: 30044597
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences.
    Bura V; Caglic I; Snoj Z; Sushentsev N; Berghe AS; Priest AN; Barrett T
    Eur Radiol; 2021 Jul; 31(7):4908-4917. PubMed ID: 33398421
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier.
    Chan I; Wells W; Mulkern RV; Haker S; Zhang J; Zou KH; Maier SE; Tempany CM
    Med Phys; 2003 Sep; 30(9):2390-8. PubMed ID: 14528961
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Utility of T
    Nketiah GA; Elschot M; Scheenen TW; Maas MC; Bathen TF; Selnæs KM;
    Sci Rep; 2021 Jan; 11(1):2085. PubMed ID: 33483545
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
    Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
    Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterizing stiffness of human prostates using acoustic radiation force.
    Zhai L; Madden J; Foo WC; Mouraviev V; Polascik TJ; Palmeri ML; Nightingale KR
    Ultrason Imaging; 2010 Oct; 32(4):201-13. PubMed ID: 21213566
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Two-centre comparative experimental study of biparametric MRI at 3.0 T with and without endorectal coil using kiwifruit (Actinidia deliciosa) as a phantom for human prostate.
    Murer S; Scheidler J; Mueller-Lisse UL; Helling M; Scherr M; Mueller-Lisse UG
    Eur Radiol Exp; 2019 Aug; 3(1):30. PubMed ID: 31410699
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diffusion-weighted imaging in the assessment of prostate cancer: Comparison of zoomed imaging and conventional technique.
    Brendle C; Martirosian P; Schwenzer NF; Kaufmann S; Kruck S; Kramer U; Notohamiprodjo M; Nikolaou K; Schraml C
    Eur J Radiol; 2016 May; 85(5):893-900. PubMed ID: 27130048
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization and stratification of prostate lesions based on comprehensive multiparametric MRI using detailed whole-mount histopathology as a reference standard.
    Starobinets O; Simko JP; Kuchinsky K; Kornak J; Carroll PR; Greene KL; Kurhanewicz J; Noworolski SM
    NMR Biomed; 2017 Dec; 30(12):. PubMed ID: 28961382
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Detection of Prostate Cancer: Quantitative Multiparametric MR Imaging Models Developed Using Registered Correlative Histopathology.
    Metzger GJ; Kalavagunta C; Spilseth B; Bolan PJ; Li X; Hutter D; Nam JW; Johnson AD; Henriksen JC; Moench L; Konety B; Warlick CA; Schmechel SC; Koopmeiners JS
    Radiology; 2016 Jun; 279(3):805-16. PubMed ID: 26761720
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications.
    Vargas HA; Akin O; Franiel T; Goldman DA; Udo K; Touijer KA; Reuter VE; Hricak H
    Radiology; 2012 Mar; 262(3):894-902. PubMed ID: 22357889
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
    Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
    Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Electrical conductivity-based contrast imaging for characterizing prostatic tissues: in vivo animal feasibility study.
    Cho YS; Hur YH; Seon HJ; Kim JW; Kim HJ
    BMC Urol; 2019 Oct; 19(1):95. PubMed ID: 31638952
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fully automated localization of prostate peripheral zone tumors on apparent diffusion coefficient map MR images using an ensemble learning method.
    Zabihollahy F; Ukwatta E; Krishna S; Schieda N
    J Magn Reson Imaging; 2020 Apr; 51(4):1223-1234. PubMed ID: 31456317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.